Table 1.
Clinicopathological characteristics of patients included in this study.
| Characteristics | Units | N = 61 |
|---|---|---|
| Age | (years) * | 67 (38–83) |
| Sex | (male/female) | 47/14 |
| Habitual drinker | (yes/no) | 27/34 |
| Smoking | (0/<40/≥40 pack-years) | 38/11/12 |
| Hepatitis virus | (B/C/NBNC) | 13/33/15 |
| Albumin | (g/mL) * | 3.8 (3.0–4.9) |
| ALT | (IU/L) * | 44 (8–224) |
| Platelet count | (104/μL) * | 14.9 (6.0–45.6) |
| Total bilirubin | (mg/dL) * | 0.7 (0.3–1.7) |
| Prothrombin time | (%) * | 91 (68–136) |
| AFP | (ng/mL) * | 13 (2–60,514) |
| DCP | (mAU/mL) * | 184 (0–129,000) |
| Tumor | size (mm) * | 48 (12–170) |
| Grade of HCC | (W/M/P) | 19/38/4 |
| Fibrosis stage of NT | (F0–1/F2/F3/F4) | 18/14/10/19 |
| Steatosis in NT | (%) * | 1.3 (0.0–23.3) |
*
Date shown as median value (range).
Abbreviations: AFP, alpha-fetoprotein; ALT, alanine aminotransferase; B, positive for HBsAg; C, positive for anti-HCV; DCP, des-gamma-carboxy prothrombin; HCC, hepatocellular carcinoma; M, moderately differentiated; NBNC, negative for HBsAg and anti-HCV; NT, non-tumorous liver tissue; P, poorly differentiated; W, well differentiated.